<DOC>
	<DOCNO>NCT00807924</DOCNO>
	<brief_summary>The purpose patient track program monitor long term safety effectiveness Novilase™ device method real world application .</brief_summary>
	<brief_title>American Breast Laser Ablation Therapy Evaluation</brief_title>
	<detailed_description>ABLATE prospective , observational multi-center track database evaluate clinical outcome patient undergo Novilase benign breast condition ( i.e . fibroadenoma , papilloma , etc ) . Data capture assess potential advantage disadvantage procedure compare lumpectomy . Tumor characteristic , equipment use , complication , patient satisfaction cosmesis rating also track .</detailed_description>
	<mesh_term>Fibroadenoma</mesh_term>
	<criteria>Diagnosis confirm needle core biopsy Tumors detect either physical exam image Tumors exceed 2 cm diameter measure least 0.5 cm away skin chest wall Single , multiple and/or bilateral tumor Patient give consent prior treat Novilase™ Patient pregnant lactate Hypercellularity suggestive phyllode Atypia Equivocal pathology report ( e.g. , discordance radiographic microscopic result ) Fibroadenomas stromal solidarity</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Fibroadenomas</keyword>
	<keyword>Papillomas</keyword>
	<keyword>Breast</keyword>
	<keyword>Minimally invasive</keyword>
	<keyword>Interstitial laser therapy</keyword>
	<keyword>Laser ablation</keyword>
	<keyword>Benign</keyword>
	<keyword>Non-cancerous</keyword>
	<keyword>Breast lesion</keyword>
	<keyword>Breast tumor</keyword>
</DOC>